glp 1 conference GLP-1 agonists could be a global game-changer, but need to be accessible and affordable Moving Beyond GLP-1: The Next

Individuals with CKD also have impaired potassium tolerance, making them susceptible to postprandial hyperkalemia [33]

10.1152/jappl.1999.87.1.438 J Appl Physiol

GALA + HRT Losing weight in menopause is hard

Melanotan-2 FDA Approved Status: Side Effects and Safety Profile The clinical trial data that does exist for Melanotan-2 shows a consistent side effect profile across multiple studies

Somatostatin analogue SMS 201-995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy

This research does not provide a peptide treatment but rather identifies a peptide pathway that could be targeted to reduce eczema-associated itch, potentially through BNP receptor antagonists